abbott realtime hbv assay (Abbott Laboratories)
86
Structured Review
Abbott Laboratories
abbott realtime hbv assay
Abbott Realtime Hbv Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/abbott+realtime+hbv+assay/1+abbott+assay+hiv+realtime/pm41240660-74-9-9
Average 86 stars, based on 1 article reviews
Abbott Realtime Hbv Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/abbott+realtime+hbv+assay/1+abbott+assay+hiv+realtime/pm41240660-74-9-9
Average 86 stars, based on 1 article reviews
abbott realtime hbv assay - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
In Vitro:Article Title: Article Snippet: .. Article Title: Article Snippet: .. V. DEVICE DESCRIPTION The Article Title: Article Snippet: Applicant's Name and Address: Abbott Molecular Inc., 1300 E. Touhy Avenue, Des Plaines, IL 60018 Date(s) of Panel Recommendation: None Premarket Approval Application (PMA) Number: P080026 Date of FDA Notice of Approval: August 13, 2010 Expedited: Not applicable II. .. INDICATIONS FOR USE Polymerase Chain Reaction:Article Title: Article Snippet: .. Article Title: Article Snippet: .. V. DEVICE DESCRIPTION The Article Title: Article Snippet: Applicant's Name and Address: Abbott Molecular Inc., 1300 E. Touhy Avenue, Des Plaines, IL 60018 Date(s) of Panel Recommendation: None Premarket Approval Application (PMA) Number: P080026 Date of FDA Notice of Approval: August 13, 2010 Expedited: Not applicable II. .. INDICATIONS FOR USE Quantitation Assay:Article Title: Article Snippet: .. Article Title: Article Snippet: .. V. DEVICE DESCRIPTION The Article Title: Article Snippet: Applicant's Name and Address: Abbott Molecular Inc., 1300 E. Touhy Avenue, Des Plaines, IL 60018 Date(s) of Panel Recommendation: None Premarket Approval Application (PMA) Number: P080026 Date of FDA Notice of Approval: August 13, 2010 Expedited: Not applicable II. .. INDICATIONS FOR USE Virus:Article Title: Article Snippet: .. Article Title: Article Snippet: Applicant's Name and Address: Abbott Molecular Inc., 1300 E. Touhy Avenue, Des Plaines, IL 60018 Date(s) of Panel Recommendation: None Premarket Approval Application (PMA) Number: P080026 Date of FDA Notice of Approval: August 13, 2010 Expedited: Not applicable II. .. INDICATIONS FOR USE Clinical Proteomics:Article Title: Article Snippet: .. Article Title: Article Snippet: .. V. DEVICE DESCRIPTION The Article Title: Article Snippet: Applicant's Name and Address: Abbott Molecular Inc., 1300 E. Touhy Avenue, Des Plaines, IL 60018 Date(s) of Panel Recommendation: None Premarket Approval Application (PMA) Number: P080026 Date of FDA Notice of Approval: August 13, 2010 Expedited: Not applicable II. .. INDICATIONS FOR USE Sample Prep:Article Title: Article Snippet: .. Within-Laboratory Precision (Operator-to-Operator) The within-run, between-run, and between-technician (operator) precision of the other:Article Title: Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients. Article Snippet: seroclearance, corresponding to an annual rate of 8.76%.. Lower baseline HBcrAg levels correlated with an increased likelihood of HBeAg seroclearance (log-rank P < .001).. When HBcrAg kinetics were assessed based on baseline and year 3 levels, patients with HBcrAg levels persistently < 105 KU/mL (HR: 2.66; 95% CI: 1.75–4.04) and those declining to < 105 KU/mL (HR: 2.31; 95% CI: 1.50– 3.55) had an increased likelihood of HBeAg seroclearance when compared to those with persistently high HBcrAg levels. |